Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jullien

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|June 4, 2016
Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective studyE Guinard, C Bulai Livideanu, H Barthélémy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 17, 2019
Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQM Masson Regnault, J Castañeda-Sanabria, M H T Diep Tran, et al.
Annales De Dermatologie Et De Venereologie|October 30, 2021
Treatment of Eosinophilic Annular Erythema: Retrospective multicenter study and literature reviewM Chastagner, J Shourik, M Jachiet, et al.
Annales De Dermatologie Et De Venereologie|February 8, 2021
Acute acral eruptions in children during the COVID-19 pandemic: Characteristics of 103 children and their family clustersT Hubiche, A Phan, S Leducq, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 14, 2017
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohortE Sbidian, C Giboin, H Bachelez, et al.
Annales De Dermatologie Et De Venereologie|April 30, 2024
Promoting clinical research in community-based practice: Threats and opportunitiesF Poizeau, A Maruani, D Staumont-Sallé, et al.
Annales De Dermatologie Et De Venereologie|April 2, 2019
[Update of the French recommendations for the management of pemphigus]L Jelti, C Prost-Squarcioni, S Ingen-Housz-Oro, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 19, 2021
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional studyS K Mahil, M Yates, Z Z N Yiu, et al.
The British Journal of Dermatology|September 6, 2019
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effectD M Chen, A Odueyungbo, E Csinady, et al.
Annales De Dermatologie Et De Venereologie|July 16, 2024
Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithmF Poizeau, S Leducq, L Fardet, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Journal of the European Academy of Dermatology and Venereology : JEADV|June 4, 2016
Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective studyE Guinard, C Bulai Livideanu, H Barthélémy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 17, 2019
Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQM Masson Regnault, J Castañeda-Sanabria, M H T Diep Tran, et al.
Annales De Dermatologie Et De Venereologie|October 30, 2021
Treatment of Eosinophilic Annular Erythema: Retrospective multicenter study and literature reviewM Chastagner, J Shourik, M Jachiet, et al.
Annales De Dermatologie Et De Venereologie|February 8, 2021
Acute acral eruptions in children during the COVID-19 pandemic: Characteristics of 103 children and their family clustersT Hubiche, A Phan, S Leducq, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 14, 2017
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohortE Sbidian, C Giboin, H Bachelez, et al.
Annales De Dermatologie Et De Venereologie|April 30, 2024
Promoting clinical research in community-based practice: Threats and opportunitiesF Poizeau, A Maruani, D Staumont-Sallé, et al.
Annales De Dermatologie Et De Venereologie|April 2, 2019
[Update of the French recommendations for the management of pemphigus]L Jelti, C Prost-Squarcioni, S Ingen-Housz-Oro, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 19, 2021
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional studyS K Mahil, M Yates, Z Z N Yiu, et al.
The British Journal of Dermatology|September 6, 2019
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effectD M Chen, A Odueyungbo, E Csinady, et al.
Annales De Dermatologie Et De Venereologie|July 16, 2024
Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithmF Poizeau, S Leducq, L Fardet, et al.
Pageof 16